Review
Etanercept in the Treatment of Psoriatic Arthritis
Etanercept en el tratamiento de la artritis psoriásica
Leído
7710
Vecesse ha leído el artículo
2605
Total PDF
5105
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 216 | 22 | 238 |
| 2025 5 | 217 | 38 | 255 |
| 2025 4 | 187 | 23 | 210 |
| 2025 3 | 161 | 16 | 177 |
| 2025 2 | 177 | 24 | 201 |
| 2025 1 | 111 | 32 | 143 |
| 2024 12 | 98 | 20 | 118 |
| 2024 11 | 107 | 62 | 169 |
| 2024 10 | 97 | 23 | 120 |
| 2024 9 | 111 | 30 | 141 |
| 2024 8 | 120 | 48 | 168 |
| 2024 7 | 96 | 33 | 129 |
| 2024 6 | 127 | 32 | 159 |
| 2024 5 | 82 | 30 | 112 |
| 2024 4 | 104 | 28 | 132 |
| 2024 3 | 81 | 25 | 106 |
| 2024 2 | 94 | 36 | 130 |
| 2024 1 | 63 | 35 | 98 |
| 2023 12 | 89 | 26 | 115 |
| 2023 11 | 72 | 32 | 104 |
| 2023 10 | 95 | 37 | 132 |
| 2023 9 | 67 | 41 | 108 |
| 2023 8 | 40 | 13 | 53 |
| 2023 7 | 76 | 43 | 119 |
| 2023 6 | 60 | 29 | 89 |
| 2023 5 | 62 | 30 | 92 |
| 2023 4 | 60 | 25 | 85 |
| 2023 3 | 48 | 27 | 75 |
| 2023 2 | 58 | 40 | 98 |
| 2022 1 | 73 | 45 | 118 |
| 2022 12 | 83 | 36 | 119 |
| 2022 11 | 60 | 36 | 96 |
| 2022 10 | 35 | 24 | 59 |
| 2022 9 | 22 | 42 | 64 |
| 2022 8 | 28 | 34 | 62 |
| 2022 7 | 19 | 37 | 56 |
| 2022 6 | 24 | 23 | 47 |
| 2022 5 | 40 | 46 | 86 |
| 2022 4 | 58 | 39 | 97 |
| 2022 3 | 82 | 56 | 138 |
| 2022 2 | 50 | 34 | 84 |
| 2021 1 | 36 | 26 | 62 |
| 2021 12 | 27 | 37 | 64 |
| 2021 11 | 51 | 52 | 103 |
| 2021 10 | 38 | 68 | 106 |
| 2021 9 | 31 | 37 | 68 |
| 2021 8 | 24 | 40 | 64 |
| 2021 7 | 22 | 28 | 50 |
| 2021 6 | 26 | 42 | 68 |
| 2021 5 | 51 | 23 | 74 |
| 2021 4 | 100 | 47 | 147 |
| 2021 3 | 82 | 21 | 103 |
| 2021 2 | 74 | 44 | 118 |
| 2020 1 | 37 | 34 | 71 |
| 2020 12 | 43 | 21 | 64 |
| 2020 11 | 32 | 22 | 54 |
| 2020 10 | 27 | 29 | 56 |
| 2020 9 | 44 | 22 | 66 |
| 2020 8 | 32 | 24 | 56 |
| 2020 7 | 26 | 33 | 59 |
| 2020 6 | 38 | 43 | 81 |
| 2020 5 | 25 | 26 | 51 |
| 2020 4 | 28 | 34 | 62 |
| 2020 3 | 32 | 20 | 52 |
| 2020 2 | 6 | 8 | 14 |
| 2020 1 | 4 | 16 | 20 |
| 2019 12 | 4 | 1 | 5 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 1 | 5 |
| 2019 6 | 3 | 34 | 37 |
| 2019 5 | 5 | 24 | 29 |
| 2019 4 | 2 | 10 | 12 |
| 2019 3 | 0 | 4 | 4 |
| 2019 2 | 3 | 5 | 8 |
| 2019 1 | 3 | 2 | 5 |
| 2018 12 | 0 | 6 | 6 |
| 2018 11 | 2 | 1 | 3 |
| 2018 10 | 5 | 0 | 5 |
| 2018 9 | 5 | 1 | 6 |
| 2018 8 | 0 | 10 | 10 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 0 | 3 | 3 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 0 | 2 | 2 |
| 2018 2 | 26 | 6 | 32 |
| 2018 1 | 30 | 16 | 46 |
| 2017 12 | 43 | 10 | 53 |
| 2017 11 | 32 | 10 | 42 |
| 2017 10 | 28 | 11 | 39 |
| 2017 9 | 25 | 6 | 31 |
| 2017 8 | 31 | 10 | 41 |
| 2017 7 | 23 | 15 | 38 |
| 2017 6 | 27 | 19 | 46 |
| 2017 5 | 22 | 24 | 46 |
| 2017 4 | 38 | 23 | 61 |
| 2017 3 | 13 | 51 | 64 |
| 2017 2 | 16 | 12 | 28 |
| 2016 1 | 22 | 10 | 32 |
| 2016 12 | 24 | 7 | 31 |
| 2016 11 | 41 | 9 | 50 |
| 2016 10 | 29 | 16 | 45 |
| 2016 9 | 0 | 5 | 5 |
| 2016 7 | 8 | 4 | 12 |
| 2016 6 | 6 | 6 | 12 |
| 2016 5 | 8 | 3 | 11 |
| 2016 4 | 11 | 5 | 16 |
| 2016 3 | 9 | 8 | 17 |
| 2016 2 | 9 | 7 | 16 |
| 2015 1 | 10 | 2 | 12 |
| 2015 12 | 7 | 3 | 10 |
| 2015 11 | 14 | 8 | 22 |
| 2015 10 | 1 | 6 | 7 |
| 2015 8 | 0 | 6 | 6 |
| 2015 7 | 5 | 10 | 15 |
| 2015 6 | 2 | 13 | 15 |
| 2015 5 | 11 | 6 | 17 |
Mostrar todo
